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Abstract 
Purpose: To examine the prevalence and awareness of metabolic syndrome (MetS) in high-risk 
individuals attending 30 internal medicine clinics in Amman, Jordan, and also to evaluate the various 
factors associated with increased risk of MetS among them. 
Methods: This retrospective cross-sectional study was carried out across Amman, Jordan from October 
to December 2014. During the study period, 900 high-risk individuals (with hypertension, diabetes, 
central obesity and/or dyslipidemia) were recruited from thirty internal medicine clinics in Amman, 
Jordan. Data collection forms were filled based on patient interview and medical case file. 
Results: The prevalence of MetS among high-risk individuals was around 40 % (361/900), with around 
79 % (284/361) of MetS patients unaware of their condition. Older age, lower income and family history 
of premature cardiovascular diseases were associated with a higher prevalence of MetS.   
Conclusion: Although MetS was found to be highly prevalent among high-risk individuals in this study, 
the awareness of the condition in this group is very poor. These findings support the need for 
educational programs that involve both health care providers and patients. These programs should 
especially target those at risk of MetS, in order to improve awareness of the concept of MetS.  
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Cardiovascular diseases (CVDs) are the leading 
cause of death worldwide [1]. Despite the various 
and intensive management protocols used, many 
patients fail to achieve their desired clinical 
outcomes. Insulin resistance, elevated blood 
pressure, central obesity, atherogenic 
dyslipidemia, genetic susceptibility, 
hypercoagulable state, and chronic stress are 
among the most important risk factors of CVDs 
[2]. 
 
There have been numerous definitions of MetS 
[3-5], but the most commonly used definition at 
present is the one provided by the American 
Heart Association/National Heart, Lung, and 
Blood Institute which defines MetS as the 
occurrence of at least 3 of the following 5 cardio-
metabolic components:  fasting  blood glucose ≥ 
100 mg/dl, blood pressure ≥ 130/85 mmHg, 
triglycerides ≥ 150 mg/dl, HDL-C < 40 mg/dl in 
males or < 50 mg/dl in  females, waist 
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circumference ≥ 102 cm (40 in) in males or ≥ 88 
cm (35 in) in females [5]. 
 
The constellation of three or more of the fore 
mentioned metabolic risk factors and their 
imminent link to insulin resistance and 
consequently to CVDs have suggested the 
notion of metabolic syndrome (MetS). Although it 
started as a concept, MetS is a diagnosis that is 
based on the presence of three or more of its 
components [5].There is an increasing need for 
raising the awareness of MetS, especially among 
patients at risk for diabetes and cardiovascular 
disease. Patients should be aware that the fore 
listed metabolic abnormalities are more likely to 
cluster than occur separately, and when they 
coexist, they are almost certainly related to 
insulin resistance and the associated 
hyperinsulinemia. 
 
The prevalence of MetS continues to increase 
globally [6-8]. Prevalence rates reported in the 
literature are variable and related to the definition 
used, age, gender, race, and other factors [6-8]. 
Depending on definition, MetS affects between 
21 and 38.9 % of the US population [6,7]. In 
Jordan, the prevalence of MetS was found to be 
37.4 % in Jordanian individuals aged 25 years 
and older [8]. 
 
Introduction of lifestyle changes, that 
accommodate specific recommendations on diet 
and exercise, is the initial intervention of choice 
for high-risk individuals [9]. Pharmacological 
therapy is to be considered for those who fail to 
sufficiently modify their risk factors by following 
lifestyle changes [9]. Improving awareness of 
MetS is essential to execute risk reduction 
behaviors, and prevent its devastating 
complications, especially among high risk group. 
However, it is reportedly low [10,11].  
 
This study aimed to assess the prevalence and 
awareness of MetS among high risk individuals. 
It also aimed to investigate the various risk 





Study design, setting and subjects 
 
This is a retrospective cross-sectional study that 
was carried out across thirty internal medicine 
clinics in Amman-Jordan. The study commenced 
in October-2014. In order to gain the participation 
of as many individuals as possible, a 
convenience sampling method was employed at 
the clinics over three months period depending 
on throughput rate of the clinics. Inclusion criteria 
were: 1) adult individuals 18 years of age and 
above,  2) with any confirmed component of 
MetS (NCEP/ATP III): confirmed diagnosis of 
diabetes, confirmed diagnosis of hypertension, 
waist circumference ≥ 102 cm in males or ≥ 88 
cm in females, recent triglyceride value  ≥ 150 
mg/dl (taken within the last 6 months), recent 
HDL-C < 40 mg/dl in males or < 50 mg/dl in 
females (taken within the last 6 months), 3) and 
willingness to participate in the study.  
 
Research assistants (pharmacists) were trained 
to conduct the data collection process in the 
same manner (to decrease the risk of 
assessment bias). During the study period, a 
convenient sample of 900 individuals out of 990 
who fulfilled the inclusion criteria were recruited 
(response rate 90.9 %). All participants were 
required to provide a written informed consent 
before the interview, participants’ confidentiality 
was preserved. Study protocol was conducted in 
accordance with the World Medical Association 
Declaration of Helsinki guidelines [12]. Ethical 
approval was obtained from the University of 




All participants were assessed for their socio-
demographic data including: participants age, 
gender, educational level, income, smoking, 
drinking alcohol, physical activities, dietary 
pattern, and whether there is any family history of 
premature CVDs (definite myocardial infarction 
or sudden death before age 55 years in father or 
other male first-degree relative, or before age 65 
years in mother or other female first-degree 
relative). The components of metabolic 
syndrome were evaluated using patient medical 
records for hypertension, diabetes, recent 
triglyceride and recent HDL-C values (based on 
recent laboratory tests of up to 6 months). Waist 
circumference was also measured for all 
participants. All patients were asked whether 
they were aware of the presence of MetS or not. 
 
Statistical analysis  
 
Data were analyzed with Statistical Package for 
Social Sciences SPSS version 17 (SPSS, Inc., 
Chicago, IL, USA). Descriptive analysis was 
done using mean and standard deviation (SD) for 
continuous variables and percentage for 
qualitative variables. Chi-square test was used to 
evaluate differences between groups for 
categorical variables. All variables found to have 
significant association with having MetS in 
bivariate analysis were entered into logistic 
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regression analysis to determine which factors 
have the strongest association. P < 0.05 was 





A total of 900 participants were recruited in this 
study. Mean age of participants was 55 years; 
females represented 52.1 % (470) of the studied 
sample. The majority 62.7 % (564) of participants 
had earned a bachelor's degree. The 
demographic details of the sample are 
summarized in Table 1. 
In this study, the prevalence of MetS 
components was assessed for all participants 
(Figure 1). Among the studied components, 
central obesity was the most prevalent 
component, while low HDL-C was the least 
prevalent. The number of MetS components was 
evaluated; 361 participants had three or more 
components, resulting in a prevalence of MetS of 
around 40 %. When those participants were 
asked if they know that they suffer from MetS, 
only 21.3 % (77/361) of those participants were 
aware of having the condition. 
 
The investigation of factors affecting the 
prevalence of MetS showed that the prevalence 
was higher among older participants (p = 0.000). 
Lower education and lower income were also 
associated with higher risk of MetS (p = 0.000 for 
both). The presence of positive family history of 
premature CVDs was found to be linked to higher 
prevalence of MetS (p = 0.028). No difference in 
MetS prevalence was related to gender or 
lifestyle habits (alcohol drinking, smoking, 
performing exercises, and dietary pattern). 
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$ Chi square test; * Significant at p<0.05 significance level; # some questions have missing data  
 
 
Figure 1: Proportion of variousMetS components among the study sample. Note: TG: triglyceride, HDL-C: high 
density lipoprotein-cholesterol, WC: waist circumference 
 
Table 2: Results of logistic regression analysis of factors associated with risk of having MetS   (having MetS 
coded 1, not having MetS coded 0) 
 
Variable B SE P-value Odds ratio (OR) 95% CI for OR 
Age (years) 












Family history of premature 





































* Significant at p < 0.05 
 
All variables in Tables 1 that were significantly 
associated with higher prevalence of MetS in 
bivariate analysis, were entered into final logistic 
regression model (Table 2). Among those 
variables, age ≥ 50 years (p = 0.000, OR 2.144) 
and the presence of family history of premature 
CVDs (p = 0.015, OR 1.436) were significantly 
associated with higher prevalence of MetS, while 
higher income level (p = 0.018, OR 0.694) was 
significantly associated with lower prevalence of 
MetS. A test of the final model goodness of fit 
using Hosmer and Lemeshow test, showed that 





This study aimed to assess the prevalence and 
awareness of MetS among high risk individuals 
attending internal medicine clinic in Jordan. It 
also aimed to evaluate the effect of various risk 
factors on the prevalence of this disorder. 
The prevalence of MetS among high risk 
individuals was found to be 40 % (361/900), this 
was similar to the prevalence rate reported by a 
previous study from Jordan (37.4 %) [8].The 
most interesting finding, and possibly the most 
alarming one, in this study is the fact that 78.6 % 
(284/361) of MetS patients are unaware of their 
condition. This finding agrees with  that reported 
by a multicentre Greek Study, where two third of 
subjects with metabolic syndrome were unaware 
of the MetS condition [11].This low awareness 
demonstrates the limited penetration of the 
concept of MetS among both patients and health 
care providers who most commonly tend to 
rather treat each component separately, instead 
of shedding light on the cluster of these 
conditions together in the form of MetS, and 
informing their patients about its associated risk 
of insulin resistance [13]. Since awareness of 
MetS is essential to implement risk reduction 
behaviors, that can potentially reduce the risk of 
CVDs, these results highlight the poor 
awareness of this condition and the necessity of 
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educating, both health care providers and 
patients, about the clustering of these cardio-
metabolic components, and its associated 
increased risk of CVDs. 
 
Among MetS components, central obesity was 
found to be the most prevalent (61 %), while low 
HDL-C was the least prevalent (27 %). In the 
literature the prevalence of different components 
varied considerably with some components being 
the most prevalent in some studies and least 
prevalent in other studies [14,15]. The high 
prevalence rate of central obesity in this study is 
consistent with the reported increasing rate in the 
literature [16]. 
 
The evaluation of risk factors and their 
association with MetS, older age was found to 
increase the risk of MetS. This conclusion is 
consistent with a previous report, where 
increasing age was found to affect the 
prevalence of MetS [14]. Individuals with lower 
income showed increased risk of MetS. Similar 
finding was found in a study from china, which 
highlighted a higher prevalence of MetS in 
females with lower income [17], while another 
study showed that higher income was associated 
with increased odds of having MetS among 
males [18]. 
 
The presence of positive family history of 
premature CVDs was associated with higher risk 
of MetS. This finding is consistent with a previous 
study that concluded a positive association of a 
positive family history of CVDs and the risk of 
MetS [8]. MetS is known to have a strong genetic 
component; higher prevalence of MetS 
components among parents is expected to be 
associated with higher prevalence of MetS 
components among their offspring generation 
[19]. 
 
In our study, no gender related differences in the 
prevalence of MetS were found. In the literature 
however, there were great controversial findings 
regarding the influence of gender on MetS 
prevalence. In many studies, prevalence of MetS 
was significantly higher in females than males 
[15,20]. But in a study by Sobko et al, they found 
that age-adjusted prevalence of MetS was over 
two times higher in males (10.5 %) than in 
females (3.7 %) [17]. Other studies showed 
similar frequency of occurrence of the MetS for 
both males and females [21]. 
 
In this study, patients’ education was found to be 
significantly associated with MetS prevalence in 
bivariate analysis, but not in multiple logistic 
regressions. Several previous studies evaluated 
the effect of educational level on the prevalence 
of MetS with conflicting results [18,20,22]. One 
study from Korea showed that the relative risk of 
MetS was two times higher in those with no or an 
elementary school education versus university 
graduation [22]. Another study showed that those 
with higher education had higher odds of having 
MetS after adjusting for age [18]. While the level 
of education, had no significant differences 
between patients with MetS and those without in 
a third study [20]. 
 
The effect of different lifestyle habits was 
previously investigated in the literature [8,20,23]. 
In our study, no difference in MetS prevalence 
was related to smoking or performing exercises. 
This finding was similar to previous studies 
where smoking status and physical activity did 
not show any statistically significant difference 
between individuals with MetS and those without 
[8,20].We also concluded that dietary patterns 
showed no effect on MetS prevalence, which 
was inconsistent with finding from the Adventist 
Health Study 2 that showed a lower risk of MetS 
among vegetarians compared to non-vegetarians 
[23]. In our study alcohol consumption showed 
no beneficial or harmful effect on the prevalence 
of MetS, while a study from USA found that mild 
to moderate alcohol consumption is associated 
with a lower prevalence of the MetS [24]. In 
contrast another study showed that continuous 
drinking, especially moderate-to-heavy drinking, 
is associated with developing MetS in men [25]. 
 
Limitations of the study 
 
Although this study has a relatively large sample 
size, we are aware of the main methodological 
limitation; since we relied on participants medical 
file to assess the presence of different MetS 
components (hypertension, diabetes, triglyceride 
and HDL-C) rather than evaluating these 
parameters by obtaining blood samples and 
measuring blood pressure values, accordingly 
our study might have underestimated the actual 
prevalence rate of MetS. This may result in 
excluding many high risk individuals who have 
either impaired blood glucose level (blood 
glucose ≥ 100 mg/dl) or those with high blood 
pressure (systolic blood pressure ≥ 135 mmHg 




The findings of this study reveal a high 
prevalence rate of MetS among high risk 
individuals in Jordan. This study have also 
shown the unexpected, and alarming poor 
awareness of MetS among this high risk 
population who should, presumably, have better 
awareness of this condition. Awareness of MetS 
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is a prerequisite for introducing lifestyle changes 
that can modify the risk of CVDs. Despite the 
worrying low awareness, it should be highlighted, 
that most of these patients at high risk, have 
chronic illnesses that will demand their regular 
visits for their physicians. This offers an 
opportunity for physicians to reach out to this 
important group of patients and educate them, 
and thus improve their awareness of MetS and 
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